Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuangrat Phodha

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|March 1, 2025
Human Papillomavirus Vaccination for Boys: Insights into Knowledge, Acceptance, and Willingness to Pay among Parents in Yogyakarta, IndonesiaDwi Endarti, Rizka Prita Yuliani, Tuangrat Phodha
Expert Review of Pharmacoeconomics & Outcomes Research|October 16, 2018
Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in ThailandTuangrat Phodha, Arthorn Riewpaiboon, Kumthorn Malathum, et al.
Journal of Pharmaceutical Policy and Practice|December 5, 2024
The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocolPiyapat Owat, Chaoncin Sooksriwong, Hataiwan Ratanabunjerdkul, et al.
Journal of Market Access & Health Policy|March 27, 2026
Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in ThailandPiyapat Owat, Chaoncin Sooksriwong, Hataiwan Ratanabunjerdkul, et al.
Journal of Pharmaceutical Policy and Practice|March 20, 2024
Value of pharmacy services for common illness symptoms covered by universal coverage at drugstore compared to outpatient services at a hospital in ThailandParun Rutjanathamrong, Tuangrat Phodha, Thanawat Wongphan, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 5, 2025
Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in ThailandJongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, et al.
Journal of Pharmaceutical Policy and Practice|September 2, 2025
The impact of alternative care pathways adopted during the COVID-19 pandemic on the management of non-communicable diseases at a tertiary care hospital in ThailandJongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, et al.
Plos One|July 3, 2025
Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in ThailandChaoncin Sooksriwong, Ekapong Kachai, Wanruchada Katchamart, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 24, 2025
Budget Impact and Cost-Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in ThailandPoukwan Arunmanakul, Tuangrat Phodha, Sakkarin Pinta-Ay, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in ThailandKittiya Jantarathaneewat, Tuangrat Phodha, Kankanit Singhasenee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Asian Pacific Journal of Cancer Prevention : APJCP|March 1, 2025
Human Papillomavirus Vaccination for Boys: Insights into Knowledge, Acceptance, and Willingness to Pay among Parents in Yogyakarta, IndonesiaDwi Endarti, Rizka Prita Yuliani, Tuangrat Phodha
Expert Review of Pharmacoeconomics & Outcomes Research|October 16, 2018
Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in ThailandTuangrat Phodha, Arthorn Riewpaiboon, Kumthorn Malathum, et al.
Journal of Pharmaceutical Policy and Practice|December 5, 2024
The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocolPiyapat Owat, Chaoncin Sooksriwong, Hataiwan Ratanabunjerdkul, et al.
Journal of Market Access & Health Policy|March 27, 2026
Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in ThailandPiyapat Owat, Chaoncin Sooksriwong, Hataiwan Ratanabunjerdkul, et al.
Journal of Pharmaceutical Policy and Practice|March 20, 2024
Value of pharmacy services for common illness symptoms covered by universal coverage at drugstore compared to outpatient services at a hospital in ThailandParun Rutjanathamrong, Tuangrat Phodha, Thanawat Wongphan, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 5, 2025
Beyond the COVID-19 Pandemic: Budget Impact Analysis of Remote Healthcare Delivery for Hypertension and Diabetes Mellitus Management in ThailandJongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, et al.
Journal of Pharmaceutical Policy and Practice|September 2, 2025
The impact of alternative care pathways adopted during the COVID-19 pandemic on the management of non-communicable diseases at a tertiary care hospital in ThailandJongkonnee Chongpornchai, Tuangrat Phodha, Thanawat Wongphan, et al.
Plos One|July 3, 2025
Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in ThailandChaoncin Sooksriwong, Ekapong Kachai, Wanruchada Katchamart, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 24, 2025
Budget Impact and Cost-Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in ThailandPoukwan Arunmanakul, Tuangrat Phodha, Sakkarin Pinta-Ay, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in ThailandKittiya Jantarathaneewat, Tuangrat Phodha, Kankanit Singhasenee, et al.
Pageof 2